Serdar Cömert

Serdar Cömert

Auto-generated profile, based on publicly available information

Serdar Cömert

SBÜ, İstanbul Eğitim Araştırma Hastanesi, Süleymaniye Ek Hizmet Binası

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2010 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
SUS Uslu
S Uslu
HOH Ozdemir
H Ozdemir
SCSerdar Comert
Serdar Comert
FBF Bolat
F Bolat
ANA Nuhoglu
A Nuhoglu

1 December 2006 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SCSerdar Comert
Serdar Comert
AVAyça Vitrinel
Ayça Vitrinel
HGHazim Alper Gursu
Hazim Alper Gursu
NDNeslihan Çiçek Deniz
Neslihan Çiçek Deniz
YAYasemin Akin
Yasemin Akin

17 July 2020 in Istanbul Medical Journal
Verified
Journal Article
Closed access
GÖGamze Özgürhan
Gamze Özgürhan
SCSerdar Comert
Serdar Comert

1 May 2022 in Istanbul Medical Journal
Verified
Journal Article
Closed access
NKNursu Kara
Nursu Kara
DADidem Arman
Didem Arman
AGAdem Gül
Adem Gül
TŞTürkan Şimşek
Türkan Şimşek
ÖCÖzben Ceylan
Özben Ceylan
SCSerdar Comert
Serdar Comert

1 September 2019 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
BHBülent Hacıhamdioğlu
Bülent Hacıhamdioğlu
GÖGamze Özgürhan
Gamze Özgürhan
CPCatarina Pereira
Catarina Pereira
ETEmre Tepeli
Emre Tepeli
GAGülşen Acar
Gülşen Acar
SCSerdar Comert
Serdar Comert
Hypophosphatasia (HPP) is a rare disease caused by mutations in the ALPL gene encoding tissue-non-specific isoenzyme of alkaline phosphatase (TNSALP). Duplications of the ALPL gene account for fewer than 1 % of the mutations causing HPP. It has been shown that asfotase alfa enzyme replacement treatment (ERT) mineralizes the skeleton and improves respiratory function and survival in severe forms of HPP. Our patient was a newborn infant evaluated for respiratory failure and generalized hypotonia after birth. Diagnosis of HPP was based on low-serum ALP activity, high concentrations of substrates of the TNSALP and radiologic findings. On day 21 after birth, ERT using asfotase alfa (2 mg/kg three times per week, subcutaneous injection) was started. His respiratory support was gradually reduced and skeletal mineralization improved during treatment. We were able to discharge the patient when he was seven months old. No mutation was detected in the ALPL gene by all exon sequencing, and additional analysis was done by quantitative polymerase chain reaction (qPCR). As a result, a novel homozygote duplication encompassing exons 2 to 6 was detected. Early diagnosis and rapid intervention with ERT is life-saving in the severe form of HPP. qPCR can detect duplications if a mutation cannot be detected by sequence analysis in these patients.

9 September 2020 in Istanbul Medical Journal
Verified
Journal Article
Open access
GÖGamze Özgürhan
Gamze Özgürhan
SCSerdar Comert
Serdar Comert